메뉴 건너뛰기




Volumn 17, Issue 2, 2014, Pages 194-206

Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: A report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

(14)  Lip, Gregory Y H a   Laroche, Cecile b   Boriani, Giuseppe c   Dan, Gheorghe Andrei d   Santini, Massimo e   Kalarus, Zbigniew f   Rasmussen, Lars Hvilsted g,h   Oliveira, Mario Martins i   Mairesse, Georges j   Crijns, Harry J G M k   Simantirakis, Emmanouil l   Atar, Dan m   Maggioni, Aldo P b   Tavazzi, Luigi n  


Author keywords

Atrial fibrillation; Geographical differences; Guidelines

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PRESCRIPTION DRUG;

EID: 84922463330     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu201     Document Type: Article
Times cited : (47)

References (24)
  • 1
    • 84890100326 scopus 로고    scopus 로고
    • Projections on the number of individuals with atrial fibrillation in the European union, from 2000 to 2060
    • Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European union, from 2000 to 2060. Eur Heart J 2013;34:2746-51.
    • (2013) Eur Heart J , vol.34 , pp. 2746-2751
    • Krijthe, B.P.1    Kunst, A.2    Benjamin, E.J.3    Lip, G.Y.4    Franco, O.H.5    Hofman, A.6
  • 2
    • 33747052359 scopus 로고    scopus 로고
    • Secular trends in incidence of atrial fibrillation in olmsted county minnesota 1980 to 2000, and implications on the projections for future prevalence
    • Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted county, minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114: 119-25.
    • (2006) Circulation , vol.114 , pp. 119-125
    • Miyasaka, Y.1    Barnes, M.E.2    Gersh, B.J.3    Cha, S.S.4    Bailey, K.R.5    Abhayaratna, W.P.6
  • 3
    • 84995360016 scopus 로고    scopus 로고
    • Atrial fibrillation management: A prospective survey in esc member countries: The euro heart survey on atrial fibrillation
    • Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, et al. Atrial fibrillation management: a prospective survey in esc member countries: the euro heart survey on atrial fibrillation. Eur Heart J 2005;26:2422-34.
    • (2005) Eur Heart J , vol.26 , pp. 2422-2434
    • Nieuwlaat, R.1    Capucci, A.2    Camm, A.J.3    Olsson, S.B.4    Andresen, D.5    Davies, D.W.6
  • 4
    • 77957738116 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the european society of cardiology (esc
    • Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (esc). Europace 2010;12:1360-420.
    • (2010) Europace , vol.12 , pp. 1360-1420
    • Camm, A.J.1    Kirchhof, P.2    Lip, G.Y.3    Schotten, U.4    Savelieva, I.5    Ernst, S.6
  • 5
    • 84875508668 scopus 로고    scopus 로고
    • 2012 focused update of the esc guidelines for the management of atrial fibrillation: An update of the 2010 esc guidelines for the management of atrial fibrillation-developed with the special contribution of the european heart rhythm association
    • Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European heart rhythm association. Europace 2012;14:1385-413.
    • (2012) Europace , vol.14 , pp. 1385-1413
    • Camm, A.J.1    Lip, G.Y.2    De Caterina, R.3    Savelieva, I.4    Atar, D.5    Hohnloser, S.H.6
  • 6
    • 84897075930 scopus 로고    scopus 로고
    • Patient's values and preferences for stroke prevention in atrial fibrillation: Balancing stroke and bleeding risk with oral anticoagulation
    • Lane DA, Lip GY. Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation. Thromb Haemost 2014;111:381-3.
    • (2014) Thromb Haemost , vol.111 , pp. 381-383
    • Lane, D.A.1    Lip, G.Y.2
  • 7
    • 34249682101 scopus 로고    scopus 로고
    • Guideline-Adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation the euro heart survey on atrial fibrillation
    • Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, et al. Guideline-Adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The euro heart survey on atrial fibrillation. Am Heart J 2007;153:1006-12.
    • (2007) Am Heart J , vol.153 , pp. 1006-1012
    • Nieuwlaat, R.1    Olsson, S.B.2    Lip, G.Y.3    Camm, A.J.4    Breithardt, G.5    Capucci, A.6
  • 8
    • 80053508197 scopus 로고    scopus 로고
    • Prognosis and guideline-Adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: Implications of undertreatment and overtreatment in real-life clinical practice; The loire valley atrial fibrillation project
    • Gorin L, Fauchier L, Nonin E, Charbonnier B, Babuty D, Lip GY. Prognosis and guideline-Adherent antithrombotic treatment in patients with atrial fibrillation and atrial flutter: implications of undertreatment and overtreatment in real-life clinical practice; the Loire valley atrial fibrillation project. Chest 2011;140:911-7.
    • (2011) Chest , vol.140 , pp. 911-917
    • Gorin, L.1    Fauchier, L.2    Nonin, E.3    Charbonnier, B.4    Babuty, D.5    Lip, G.Y.6
  • 9
    • 84861753658 scopus 로고    scopus 로고
    • Oral anticoagulation use by patients with atrial fibrillation in germany adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183, 448 patients
    • Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183, 448 patients. Thromb Haemost 2012;107:1053-65.
    • (2012) Thromb Haemost , vol.107 , pp. 1053-1065
    • Wilke, T.1    Groth, A.2    Mueller, S.3    Pfannkuche, M.4    Verheyen, F.5    Linder, R.6
  • 10
    • 84895729096 scopus 로고    scopus 로고
    • A prospective survey in european society of cardiology member countries of atrial fibrillation management: Baseline results of eurobservational research programme atrial fibrillation (eorp-Af) pilot general registry
    • Lip GYH, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, et al. A prospective survey in European society of cardiology member countries of atrial fibrillation management: baseline results of eurobservational research programme atrial fibrillation (EORP-AF) pilot general registry. Europace 2014;16:308-19.
    • (2014) Europace , vol.16 , pp. 308-319
    • Lip, G.Y.H.1    Laroche, C.2    Dan, G.A.3    Santini, M.4    Kalarus, Z.5    Rasmussen, L.H.6
  • 11
    • 84892566561 scopus 로고    scopus 로고
    • Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the rhythm-Af study
    • Lip GY, Gitt AK, Le Heuzey JY, Bash LD, Morabito CJ, Bernhardt AA, et al. Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the rhythm-Af study). Am J Cardiol 2014;113:480-4.
    • (2014) Am J Cardiol , vol.113 , pp. 480-484
    • Lip, G.Y.1    Gitt, A.K.2    Le Heuzey, J.Y.3    Bash, L.D.4    Morabito, C.J.5    Bernhardt, A.A.6
  • 12
    • 84896028353 scopus 로고    scopus 로고
    • Atrial fibrillation and heart failure: A bad combination
    • Lau YC, Lane DA, Lip GY. Atrial fibrillation and heart failure: a bad combination. Am J Cardiol 2014;113:1196-7.
    • (2014) Am J Cardiol , vol.113 , pp. 1196-1197
    • Lau, Y.C.1    Lane, D.A.2    Lip, G.Y.3
  • 13
    • 84883429747 scopus 로고    scopus 로고
    • Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction
    • McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, et al. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc 2013;2:e005694.
    • (2013) J Am Heart Assoc , vol.2 , pp. e005694
    • McManus, D.D.1    Hsu, G.2    Sung, S.H.3    Saczynski, J.S.4    Smith, D.H.5    Magid, D.J.6
  • 14
    • 84876984785 scopus 로고    scopus 로고
    • Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the worcester heart failure study
    • McManus DD, Saczynski JS, Lessard D, Kinno M, Pidikiti R, Esa N, et al. Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the worcester heart failure study). Am J Cardiol 2013;111: 1460-5.
    • (2013) Am J Cardiol , vol.111 , pp. 1460-1465
    • McManus, D.D.1    Saczynski, J.S.2    Lessard, D.3    Kinno, M.4    Pidikiti, R.5    Esa, N.6
  • 15
    • 84857560125 scopus 로고    scopus 로고
    • Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: The loire valley atrial fibrillation project
    • Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, et al. Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire valley atrial fibrillation project. Eur J Heart Fail 2012;14:295-301.
    • (2012) Eur J Heart Fail , vol.14 , pp. 295-301
    • Banerjee, A.1    Taillandier, S.2    Olesen, J.B.3    Lane, D.A.4    Lallemand, B.5    Lip, G.Y.6
  • 17
  • 18
    • 84888400659 scopus 로고    scopus 로고
    • Vitamin k antagonists in heart disease: Current status and perspectives (section iii position paper of the esc working group on thrombosis-Task force on anticoagulants in heart disease
    • De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, et al. Vitamin k antagonists in heart disease: current status and perspectives (section iii). Position paper of the ESC working group on thrombosis-Task force on anticoagulants in heart disease. Thromb Haemost 2013;110:1087-107.
    • (2013) Thromb Haemost , vol.110 , pp. 1087-1107
    • De Caterina, R.1    Husted, S.2    Wallentin, L.3    Andreotti, F.4    Arnesen, H.5    Bachmann, F.6
  • 20
    • 84884864521 scopus 로고    scopus 로고
    • Antithrombotic therapy in atrial fibrillation and stent implantation: Treatment or threats by the use of triple or dual antithrombotic therapy
    • Marin F, Huber K, Lip GY. Antithrombotic therapy in atrial fibrillation and stent implantation: treatment or threats by the use of triple or dual antithrombotic therapy. Thromb Haemost 2013;110:623-5.
    • (2013) Thromb Haemost , vol.110 , pp. 623-625
    • Marin, F.1    Huber, K.2    Lip, G.Y.3
  • 21
    • 84900606777 scopus 로고    scopus 로고
    • Contemporary real life cardioversion of atrial fibrillation: Results from the multinational rhythm-Af study
    • Crijns HJ, Weijs B, Fairley AM, Lewalter T, Maggioni AP, Martin A, et al. Contemporary real life cardioversion of atrial fibrillation: results from the multinational RHYTHM-AF study. Int J Cardiol 2014;172:588-94.
    • (2014) Int J Cardiol , vol.172 , pp. 588-594
    • Crijns, H.J.1    Weijs, B.2    Fairley, A.M.3    Lewalter, T.4    Maggioni, A.P.5    Martin, A.6
  • 22
    • 84893219776 scopus 로고    scopus 로고
    • Chads2 and cha2ds2 vasc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation
    • Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos Pet al. CHADS2 and CHA2DS2 VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Europace 2014;16:202-7.
    • (2014) Europace , vol.16 , pp. 202-207
    • Letsas, K.P.1    Efremidis, M.2    Giannopoulos, G.3    Deftereos, S.4    Lioni, L.5    Korantzopoulos, P.6
  • 23
    • 84859509560 scopus 로고    scopus 로고
    • 2012 hrs/ehra/ ecas expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
    • Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 hrs/ehra/ ecas expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
    • (2012) Europace , vol.14 , pp. 528-606
    • Calkins, H.1    Kuck, K.H.2    Cappato, R.3    Brugada, J.4    Camm, A.J.5    Chen, S.A.6
  • 24
    • 84879520764 scopus 로고    scopus 로고
    • International differences in treatment effect: Do they really exist and why?
    • Pocock S, Calvo G, Marrugat J, Prasad K, Tavazzi L, Wallentin L, et al. International differences in treatment effect: do they really exist and why?. Eur Heart J 2013;34: 1846-52.
    • (2013) Eur Heart J , vol.34 , pp. 1846-1852
    • Pocock, S.1    Calvo, G.2    Marrugat, J.3    Prasad, K.4    Tavazzi, L.5    Wallentin, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.